| Literature DB >> 31877054 |
Zhaoyi Sun1, Chengjun Song2, Chao Wang2, Yiqiao Hu2,3,4, Jinhui Wu2,3,4.
Abstract
As an emerging drug carrier, hydrogels have been widely used for tumor drug delivery. A hydrogel drug carrier can cause less severe side effects than systemic chemotherapy and can achieve sustained delivery of a drug at tumor sites. In addition, hydrogels have excellent biocompatibility and biodegradability and lower toxicity than nanoparticle carriers. Smart hydrogels can respond to stimuli in the environment (e.g., heat, pH, light, and ultrasound), enabling in situ gelation and controlled drug release, which greatly enhance the convenience and efficiency of drug delivery. Here, we summarize the different sizes of hydrogels used for cancer treatment and their related delivery routes, discuss the design strategies for stimuli-responsive hydrogels, and review the research concerning smart hydrogels reported in the past few years.Entities:
Keywords: cancer; drug delivery systems; hydrogel; stimuli-responsive materials
Year: 2020 PMID: 31877054 DOI: 10.1021/acs.molpharmaceut.9b01020
Source DB: PubMed Journal: Mol Pharm ISSN: 1543-8384 Impact factor: 4.939